{"id":"https://openalex.org/W2331807641","doi":"https://doi.org/10.1097/00004714-199902000-00015","title":"Possible Gabapentin-Induced Thyroiditis","display_name":"Possible Gabapentin-Induced Thyroiditis","publication_year":1999,"publication_date":"1999-02-01","ids":{"openalex":"https://openalex.org/W2331807641","doi":"https://doi.org/10.1097/00004714-199902000-00015","mag":"2331807641","pmid":"https://pubmed.ncbi.nlm.nih.gov/9934948"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-199902000-00015","doi":"https://doi.org/10.1097/00004714-199902000-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199902000-00015","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029433360","display_name":"Mark A. Frye","orcid":"https://orcid.org/0000-0001-6997-4215","observed_orcids":["https://orcid.org/0000-0001-6997-4215"]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"id":"https://openalex.org/I4210160792","display_name":"National Institute of Mental Health","ror":"https://ror.org/04t0s7x83","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210103779","https://openalex.org/I4210160792"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Mark A. Frye","raw_affiliation_strings":["Bethesda, Maryland","National Institute of Mental Health","Health","Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda, Maryland","institution_ids":[]},{"raw_affiliation_string":"National Institute of Mental Health","institution_ids":["https://openalex.org/I4210158500","https://openalex.org/I4210160792"]},{"raw_affiliation_string":"Health","institution_ids":[]},{"raw_affiliation_string":"Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073769908","display_name":"Dave A. Luckenbaugh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"id":"https://openalex.org/I4210160792","display_name":"National Institute of Mental Health","ror":"https://ror.org/04t0s7x83","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210103779","https://openalex.org/I4210160792"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Dave Luckenbaugh","raw_affiliation_strings":["Bethesda, Maryland","National Institute of Mental Health","Health","Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda, Maryland","institution_ids":[]},{"raw_affiliation_string":"National Institute of Mental Health","institution_ids":["https://openalex.org/I4210158500","https://openalex.org/I4210160792"]},{"raw_affiliation_string":"Health","institution_ids":[]},{"raw_affiliation_string":"Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111832101","display_name":"Tim A. Kimbrell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"id":"https://openalex.org/I4210160792","display_name":"National Institute of Mental Health","ror":"https://ror.org/04t0s7x83","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210103779","https://openalex.org/I4210160792"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Tim A. Kimbrell","raw_affiliation_strings":["Bethesda, Maryland","National Institute of Mental Health","Health","Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda, Maryland","institution_ids":[]},{"raw_affiliation_string":"National Institute of Mental Health","institution_ids":["https://openalex.org/I4210158500","https://openalex.org/I4210160792"]},{"raw_affiliation_string":"Health","institution_ids":[]},{"raw_affiliation_string":"Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065552614","display_name":"Cassandra Xavier Constantino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"id":"https://openalex.org/I4210160792","display_name":"National Institute of Mental Health","ror":"https://ror.org/04t0s7x83","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210103779","https://openalex.org/I4210160792"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Cassandra Constantino","raw_affiliation_strings":["Bethesda, Maryland","National Institute of Mental Health","Health","Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda, Maryland","institution_ids":[]},{"raw_affiliation_string":"National Institute of Mental Health","institution_ids":["https://openalex.org/I4210158500","https://openalex.org/I4210160792"]},{"raw_affiliation_string":"Health","institution_ids":[]},{"raw_affiliation_string":"Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050668093","display_name":"Dale R. Grothe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"id":"https://openalex.org/I4210160792","display_name":"National Institute of Mental Health","ror":"https://ror.org/04t0s7x83","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210103779","https://openalex.org/I4210160792"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Dale Grothe","raw_affiliation_strings":["Bethesda, Maryland","National Institute of Mental Health","Health","Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda, Maryland","institution_ids":[]},{"raw_affiliation_string":"National Institute of Mental Health","institution_ids":["https://openalex.org/I4210158500","https://openalex.org/I4210160792"]},{"raw_affiliation_string":"Health","institution_ids":[]},{"raw_affiliation_string":"Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013535262","display_name":"Gabriela Cora\u2010Locatelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"id":"https://openalex.org/I4210160792","display_name":"National Institute of Mental Health","ror":"https://ror.org/04t0s7x83","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210103779","https://openalex.org/I4210160792"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Gabriela Cora-Locatelli","raw_affiliation_strings":["Bethesda, Maryland","National Institute of Mental Health","Health","Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda, Maryland","institution_ids":[]},{"raw_affiliation_string":"National Institute of Mental Health","institution_ids":["https://openalex.org/I4210158500","https://openalex.org/I4210160792"]},{"raw_affiliation_string":"Health","institution_ids":[]},{"raw_affiliation_string":"Maryland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046547929","display_name":"Terence A. Ketter","orcid":"https://orcid.org/0000-0001-5132-453X","observed_orcids":["https://orcid.org/0000-0001-5132-453X"]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"id":"https://openalex.org/I4210160792","display_name":"National Institute of Mental Health","ror":"https://ror.org/04t0s7x83","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210103779","https://openalex.org/I4210160792"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Terence A. Ketter","raw_affiliation_strings":["Bethesda, Maryland","National Institute of Mental Health","Health","Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda, Maryland","institution_ids":[]},{"raw_affiliation_string":"National Institute of Mental Health","institution_ids":["https://openalex.org/I4210158500","https://openalex.org/I4210160792"]},{"raw_affiliation_string":"Health","institution_ids":[]},{"raw_affiliation_string":"Maryland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9223,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.75102394,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"19","issue":"1","first_page":"94","last_page":"95"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":1.0},{"id":"https://openalex.org/keywords/drug-induced-thyroiditis","display_name":"drug-induced thyroiditis","score":0.9160000085830688},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7049999833106995},{"id":"https://openalex.org/keywords/thyroid-disease","display_name":"thyroid dysfunction","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.8687765598297119},{"id":"https://openalex.org/C2778696486","wikidata":"https://www.wikidata.org/wiki/Q11835644","display_name":"Thyroiditis","level":3,"score":0.6353793144226074},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6087450981140137},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33513832092285156},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.23699668049812317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23674139380455017},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11507856845855713},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.06892329454421997}],"mesh":[{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000085","descriptor_name":"Acetates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013966","descriptor_name":"Thyroiditis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D013966","descriptor_name":"Thyroiditis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-199902000-00015","doi":"https://doi.org/10.1097/00004714-199902000-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199902000-00015","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9934948","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9934948","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1989313585","https://openalex.org/W2011347417","https://openalex.org/W2021145477","https://openalex.org/W2025064072","https://openalex.org/W2053518000","https://openalex.org/W2224756467","https://openalex.org/W3028411902"],"related_works":["https://openalex.org/W4283764351","https://openalex.org/W2329152519","https://openalex.org/W2791557851","https://openalex.org/W2754540994","https://openalex.org/W2572468121","https://openalex.org/W1990557208","https://openalex.org/W3032956743","https://openalex.org/W7172497618","https://openalex.org/W2088956336","https://openalex.org/W3116938793"],"abstract_inverted_index":{"Frye,":[0],"Mark":[1],"A.":[2,9,22],"MD;":[3,10,13,19],"Luckenbaugh,":[4],"Dave":[5],"MA;":[6],"Kimbrell,":[7],"Tim":[8],"Constantino,":[11],"Cassandra":[12],"Grothe,":[14],"Dale":[15],"PharmD;":[16],"Cora-Locatelli,":[17],"Gabriela":[18],"Ketter,":[20],"Terence":[21],"MD":[23],"Author":[24],"Information":[25]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}